Nepal approves AstraZeneca Covid vaccine for emergency use

Nepal has reported 266,816 cases and 1,948 deaths from Covid-19 so far, according to official data.

Nepal on Friday granted approval for AstraZeneca's COVISHIELD vaccine against the novel coronavirus in the country.

The AstraZeneca vaccine could facilitate a rapid ramp-up of vaccinations because it’s easier to transport and store than the Pfizer-BioNTech shot (REUTERS)

"Conditional permission has been granted for emergency use authorization of COVISHIELD vaccine against Covid-19 in Nepal," a statement by the country's Department of Drug Administration said.

Nepal has reported 266,816 cases and 1,948 deaths from Covid-19 so far, according to official data.